Skip to content

BIOSILARIS

Active Private limited companyfounded 2014active for 12 yearsRue Arbre Ste-Barbe 39, 4500 HuyKBO/BCE: BE 0550.879.529

Lifetime

12 annual accounts with figures on one time axis
peak of €93,489 in 2025
€93,489▲ 27.8%
lowest -€22,517 in 2015
€66,265▲ 25.3%
peak of €222,112 in 2025
€222,112▲ 32.4%
€39,333▲ 1.4%
Board1 name since 2014
1 director
Documentsfilings and deeds
26-05-202666 days before the deadline
2025micro format
Gross margin from €73,124 to €93,489Result from €52,904 to €66,265Dividend €11,954Equity from €167,800 to €222,112Investments €9,600

Key points

from the 2025 annual accounts

Equity

€222,112 ▲ 32.4%

BIOSILARIS has made a profit without a break since 2019.

Investments

€9,600 9.7 times depreciation
202120232025

Green is investment, beige is depreciation.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Two of the last ten came late. The 2016 accounts came in latest, 24 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,724 companies had the same profile as BIOSILARIS has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,724 companies, not a prediction for BIOSILARIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 24-04-2014
  • 100 sharesdeed of 07-05-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0550879529
Registered office moved from Esneux to Huy The registered office moved from Rue de Mery, 18 à 4130 Esneux to rue Arbre Sainte-Barbe 39, 4500 Huy · reappointed as director · General meeting of 01-12-2023 · Gazette deed
Registered office moved from Vaux-sous-Chèvremont to Esneux The registered office moved from Rue du Général Jacques 32 à 4051 Vaux-sous-Chèvremont to Rue de Mery, 18 à 4130 Esneux · Board meeting of 01-10-2021 · Gazette deed
Registered office moved from Viemme to Vaux-Sous-Chèvremont The registered office moved from RUE LEON GENIE 16/2, 4317 VIEMME to Rue du Général Jacques, numéro 32 à 4051 Vaux-Sous-Chèvremont · General meeting of 14-12-2015 · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
BIOSILARIS Huy €261,445 €93,489 85.0% -
CRz Services Spa €251,152 €82,779 11.6% -
BELMA TECHNOLOGIES Liège €281,040 €42,747 98.0% -
LB&K Sprimont €394,560 €50,328 97.6% -
Cabinet de Médecine Générale André Hotermans Stoumont €364,240 €71,258 32.9% -
GFAC Beyne-Heusay €183,399 €83,330 90.6% -
Oteas Heist-op-den-Berg €193,883 €63,597 27.3% -

These companies have the same main activity as BIOSILARIS: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €183,000 and €395,000, founded between 2010 and 2015.

Official details

Source: KBO
Status
Active since 24-04-2014Normal situation
Activity
Research and development on biotechnologyNACE 72101and 5 others
Establishment unit
2.230.694.9444500 Huy, registered on 22-04-2014
Financial year end
31 December
Peppol
Reachable since 04-12-2025
Company details

Annual accounts 2025

≈ €280,000estimated
€261,445▲ 26.5%
Filing
Filed on 26-05-2026, 66 days before the end of the filing period
Financials

Insights on BIOSILARIS

BIOSILARIS files the micro format. That format states no turnover. The gross margin rose from €28,775 in 2014 to €93,489 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOSILARIS

What is the company number of BIOSILARIS?
The company number of BIOSILARIS is 0550.879.529. The VAT number is the same number with BE in front: BE 0550.879.529.
Where is BIOSILARIS based?
The registered office is at Rue Arbre Ste-Barbe 39, 4500 Huy.Company details
What does BIOSILARIS do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of BIOSILARIS?
BIOSILARIS is a private limited company (BV).
When was BIOSILARIS founded?
BIOSILARIS was founded on 24-04-2014.
Is BIOSILARIS still active?
Yes, BIOSILARIS is an active enterprise in the KBO register.
What is the turnover of BIOSILARIS?
The turnover in financial year 2025 is about €280,000. This figure is estimated from the gross margin of €93,489 and 2,989 comparable companies of the same size. It probably lies between €180,000 and €480,000. It is a rough estimate.Financials
Is BIOSILARIS profitable?
In financial year 2025, BIOSILARIS made a profit of €66,265.
Where can I find the annual accounts of BIOSILARIS?
BIOSILARIS filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOSILARIS due?
BIOSILARIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.